Bone Marrow TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsTransplantation ConditioningGraft vs Host DiseaseCombined Modality TherapyWhole-Body IrradiationHematopoietic Stem Cell MobilizationCyclophosphamideBusulfanAntigens, CD34Bone Marrow PurgingGraft SurvivalMelphalanHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorBone and BonesLymphoma, Non-HodgkinHematologic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaHematopoiesisTreatment OutcomeAnemia, AplasticCarmustineLeukemiaRemission InductionRecurrenceTransplantation ChimeraLiver TransplantationLeukapheresisTissue DonorsEtoposideLeukemia, Myeloid, AcuteT-LymphocytesBlood Component RemovalBlood Transfusion, AutologousTime FactorsHistocompatibility TestingCytarabineStem Cell TransplantationLeukocytes, MononuclearHistocompatibilityHodgkin DiseaseTransplantation, IsogeneicThiotepaBone Marrow DiseasesMyeloablative AgonistsPlatelet CountRetrospective StudiesKidney TransplantationSalvage TherapyImmunosuppressive AgentsMice, Inbred C57BLBlood Cell CountDisease-Free SurvivalSurvival AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraFlow CytometryVincristineCells, CulturedLymphocytesBone Marrow ExaminationInfectionSurvival RateLymphomaLymphocyte ActivationFatal OutcomeNeoplasmsImmunophenotypingGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaFollow-Up StudiesAntineoplastic Agents, AlkylatingCytomegalovirus InfectionsLeukemia, MyeloidHepatic Veno-Occlusive DiseaseTransplantation ImmunologyCell SeparationBone RemodelingImmunosuppressionAcute DiseaseBone Marrow NeoplasmsLymphocyte DepletionGraft vs Host ReactionColony-Forming Units AssayLeukocyte TransfusionCytophagocytosisIfosfamideLeukocyte CountHLA AntigensRecombinant ProteinsHeart TransplantationChimeraPrognosis